Is it best to remove insurance benefits from drugs prescribed in bribery?

Korea Biomedical Review

25 April 2022 - The Ministry of Health and Welfare’s Health Insurance Policy Review Committee is scheduled to hold a meeting on Friday this week to determine whether to suspend reimbursement for medicines prescribed by doctors who received bribes from pharmaceutical companies.

The upcoming decision is expected to affect various medications, industry watchers said.

Read Korea Biomedical Review article

Michael Wonder

Posted by:

Michael Wonder